MN rgp160: Started Phase I/II U.S. trial

Immuno-U.S. Inc. Product: MN rgp160 Indication: Comparison with Genentech's IIIB and MN rgp120 vaccines, and Biocine's SF2 rgp120 vaccine, as booster injections following immunization with HIVAC-1e S...